Evidence map›Paper›PMID 35337062›Full record

ReviewPharmaceuticals (Basel, Switzerland)2022

UV Filters: Challenges and Prospects.

Ana Jesus, Emília Sousa, Maria T Cruz, Honorina Cidade, José M Sousa Lobo, Isabel F Almeida

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecules (Basel, Switzerland) · 2026
    Article
  8. ACS omega · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Valorization of Hazelnut (Antioxidants (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Evaluation of Residues of Amazonian Fruit Piquia (Antioxidants (Basel, Switzerland) · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana JesusUCIBIO-Applied Molecular Biosciences Unit, MedTech, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0001-7425-9750
Emília SousaLaboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-5397-4672
Maria T CruzFaculty of Pharmacy, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0001-9846-6754
Honorina CidadeLaboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-0715-1779
José M Sousa LoboUCIBIO-Applied Molecular Biosciences Unit, MedTech, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-9518-8397
Isabel F AlmeidaUCIBIO-Applied Molecular Biosciences Unit, MedTech, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-1498-048X

Funding

Applied Molecular Biosciences Unit-UCIBIO is financed by national funds from FCT/MCTES UID/Multi/04378/2020National funds through FCT (Group of Natural Products and Medicinal Chemistry-CIIMAR) UIDB/04423/2020 and UIDP/04423/2020National funds under the project 47239 - Cork2Cosmetic NORTE-01-0247-FEDER-047239PhD research grant fully supported by national funding by FCT, Foundation for Science and Technology UI/BD/151319/2021The European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project HealthyAging2020 CENTRO-01-0145-FEDER-000012The structured program of R&D&I ATLANTIDA-Platform for the monitoring of the North Atlantic Ocean and tools for the sustainable exploitation of the marine resources, supported by the North Portugal Regional Operational Programme (NORTE2020) through the Eu NORTE-01-0145-FEDER-000040
6 · The paper itself

Abstract

The use of sunscreens is an established and recommended practice to protect skin from solar-induced damage. Around 30 UV filters can be used in sunscreen products in the European Union, which ought to follow the requirements of the regulation 1223/2009 to ensure their efficacy and safety for humans. Nevertheless, low photostability and putative toxicity for humans and environment have been reported for some UV filters. Particularly, the negative impact in marine organisms has recently raised concern on the scientific community. Therefore, it is important to develop new UV filters with improved safety profile and photostability. Over the last two decades, nearly 200 new compounds have revealed promising photoprotection properties. The explored compounds were obtained through different approaches, including exploration of natural sources, synthetic pathways, and nanotechnology. Almost 50 natural products and around 140 synthetic derivatives, such as benzimidazoles, benzotriazoles, hydroxycinnamic acids, xanthones, triazines, among others, have been studied aiming the discovery of novel, effective, and safer future photoprotective agents. Herein, we provide the reader with an overview about UV filters' challenges and prospects, offering a forward-looking to the next-generation of UV filters.

Indexed as

challengesnatural productsphotostabilityprospectssynthetic derivativestoxicityUV filters

Identifiers

PMID35337062
PMCPMC8955451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.